GLUE position history
The shares of Monte Rosa Therapeutics (GLUE) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 745,000 shares, $18M, 1.6% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|